Peer reviewed
Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa.
Antibiotics (Basel) (2023). Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa.
Antibiotics (Basel)Accessed Aug 5, 2026
Registry record
Source metadata
- Publisher
- Antibiotics (Basel)
- Source type
- Peer reviewed
- Registry ID
pubmed-ll37-polymyxinb-2023- DOI
- 10.3390/antibiotics12020389
- PMID
- 36830299
Source usage
Not yet linked from a public content page
This record may be retained for an upcoming review or for internal source normalization.
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.